Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases

BMC Systems Biology

Volumn 6, Issue , 2012, Pages

  Liu, Yu ^a   Koyutürk, Mehmet ^a,b,c   Barnholtz Sloan, Jill S ^a,c   Chance, Mark R ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Case Western Reserve University   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

BAD pathway; Dysregulated pathways; Enrichment analysis; Gene gene interaction

Indexed keywords

PROTEIN BAD; PROTEIN P53;

ARTICLE; BIOLOGY; BREAST TUMOR; DISEASES; GENE REGULATORY NETWORK; GENETIC EPISTASIS; GENETICS; HUMAN; METHODOLOGY; MUTATION; PANCREAS TUMOR; PROGNOSIS; TUMOR CELL LINE;

BCL-ASSOCIATED DEATH PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DISEASE; EPISTASIS, GENETIC; GENE REGULATORY NETWORKS; HUMANS; MUTATION; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862209073     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-65     Document Type: Article

References (44)

1. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (New York, NY) 2004, 6:1-6.
2. Liu Y, Patel S, Nibbe R, Maxwell S, Chowdhury SA, Koyuturk M, Zhu X, Larkin EK, Buxbaum SG, Punjabi NM, et al. Systems biology analyses of gene expression and genome wide association study data in obstructive sleep apnea. Proceedings of The Pacific Symposium on Biocomputing (PSB) 2011: 3-7 Jan., 2011; Big Island of Hawaii 2011, 14-23. Klein: electronic proceedings, , Russ B, Altman A, Keith D, Lawrence H, Teri E.
3. de la Fuente A. From 'differential expression' to 'differential networking' - identification of dysfunctional regulatory networks in diseases. Trends in genetics : TIG 2010, 26:326-333. 10.1016/j.tig.2010.05.001, 20570387.
4. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette M, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
5. Efron B, Tibshirani R. On testing the significance of sets of genes. Annals of Applied Statistics 2007, 1:107-129.
6. Beyer A, Bandyopadhyay S, Ideker T. Integrating physical and genetic maps: from genomes to interaction networks. Nat Rev Genet 2007, 8:699-710. 10.1038/nrg2144, 2811081, 17703239.
7. Marchini J, Donnelly P, Cardon LR. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 2005, 37:413-417. 10.1038/ng1537, 15793588.
8. Zhang J, Li J, Deng H-W. Identifying gene interaction enrichment for gene expression data. PLoS One 2009, 4:e8064. 10.1371/journal.pone.0008064, 2779493, 19956614.
9. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, Ding H, Koh JL, Toufighi K, Mostafavi S, et al. The genetic landscape of a cell. Science 2010, 327:425-431. 10.1126/science.1180823, 20093466.
10. Eddy J, Geman D, Price ND. Relative expression analysis for identifying perturbed pathways. Conference proceedings : Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Conference 2009, 2009:5456-5459.
11. James E, Hood L, Price ND, Geman D. Identifying Tightly Regulated and Variably Expressed Networks by Differential Rank Conservation (DIRAC). PLoS Comput Biol 2010, 6:e1000792. 10.1371/journal.pcbi.1000792, 2877722, 20523739.
12. Watkinson J, Wang X, Zheng T, Anastassiou D. Identification of gene interactions associated with disease from gene expression data using synergy networks. BMC Syst Biol 2008, 2:10. 10.1186/1752-0509-2-10, 2258206, 18234101.
13. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol 2007, 3:140. 2063581, 17940530.
14. Chowdhury SA, Nibbe RK, Chance MR MK. Subnetwork state functions define dysregulated subnetworks in cancer. J Comput Biol 2011, : . in press.
15. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002, 19:607-614. 10.1002/humu.10081, 12007217.
16. Ishikawa M, Yoshida K, Yamashita Y, Ota J, Takada S, Kisanuki H, Koinuma K, Choi YL, Kaneda R, Iwao T, et al. Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells. Cancer Sci 2005, 96:387-393. 10.1111/j.1349-7006.2005.00064.x, 16053509.
17. Li JY, Paragas N, Ned RM, Qiu A, Viltard M, Leete T, Drexler IR, Chen X, Sanna-Cherchi S, Mohammed F, et al. Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell 2009, 16:35-46. 10.1016/j.devcel.2008.12.002, 2652503, 19154717.
18. Li Y, Zou L, Li Q, Haibe-Kains B, Tian R, Desmedt C, Sotiriou C, Szallasi Z, Iglehart JD, Richardson AL, Wang ZC. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med 2010, 16:214-218. 10.1038/nm.2090, 2826790, 20098429.
19. de Cremoux P, Valet F, Gentien D, Lehmann-Che J, Scott V, Tran-Perennou C, Barbaroux C, Servant N, Vacher S, Sigal-Zafrani B, et al. Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients. BMC Cancer 2011, 11:215. 10.1186/1471-2407-11-215, 3126791, 21631949.
20. Newman MEJ. Modularity and community structure in networks. Proc Natl Acad Sci U S A 2006, 103:8577-8582. 10.1073/pnas.0601602103, 1482622, 16723398.
21. Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I, Zhang W. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A 2007, 104:3414-3419. 10.1073/pnas.0611373104, 1805517, 17360660.
22. Xu L, Tan AC, Winslow RL, Geman D. Merging microarray data from separate breast cancer studies provides a robust prognostic test. BMC Bioinforma 2008, 9:125.
23. Ghaffari N, Ivanov I, Qian X, Dougherty ER. A CoD-based reduction algorithm for designing stationary control policies on Boolean networks. Bioinformatics 2010, 26:1556-1563. 10.1093/bioinformatics/btq225, 20421196.
24. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, Bull S, Pawson T, Morris Q, Wrana JL. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 2009, 27:199-204. 10.1038/nbt.1522, 19182785.
25. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003, 100:9440-9445. 10.1073/pnas.1530509100, 170937, 12883005.
26. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000, 24:236-244. 10.1038/73439, 10700175.
27. Ulitsky I, Maron-Katz A, Shavit S, Sagir D, Linhart C, Elkon R, Tanay A, Sharan R, Shiloh Y, Shamir R. Expander: from expression microarrays to networks and functions. Nat Protoc 2010, 5:303-322. 10.1038/nprot.2009.230, 20134430.
28. Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F. Cancer targets in the Ras pathway. Cold Spring Harb Symp Quant Biol 2005, 70:461-467. 10.1101/sqb.2005.70.044, 16869784.
29. Bartek J, Lukas J. Cell cycle. Order from destruction. Science 2001, 294:66-67.
30. Momand J, Wu HH, Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein. Gene 2000, 242:15-29. 10.1016/S0378-1119(99)00487-4, 10721693.
31. Hershko T, Chaussepied M, Oren M, Ginsberg D. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ 2005, 12:377-383. 10.1038/sj.cdd.4401575, 15706352.
32. Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta 2009, 1787:414-420. 10.1016/j.bbabio.2008.10.005, 2819081, 19007744.
33. Regula KM, Kirshenbaum LA. p53 activates the mitochondrial death pathway and apoptosis of ventricular myocytes independent of de novo gene transcription. J Mol Cell Cardiol 2001, 33:1435-1445. 10.1006/jmcc.2001.1405, 11448132.
34. Jane EP, Premkumar DR, Pollack IF. AG490 influences UCN-01-induced cytotoxicity in glioma cells in a p53-dependent fashion, correlating with effects on BAX cleavage and BAD phosphorylation. Cancer Lett 2007, 257:36-46. 10.1016/j.canlet.2007.06.020, 2055549, 17900801.
35. Jiang P, Du W, Wu M. p53 and Bad: remote strangers become close friends. Cell Res 2007, 17:283-285. 10.1038/cr.2007.19, 17404594.
36. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol 2002, 22:965-977. 10.1128/MCB.22.3.965-977.2002, 133541, 11784871.
37. Chen J, Xu XM, Underhill CB, Yang S, Wang L, Chen Y, Hong S, Creswell K, Zhang L. Tachyplesin activates the classic complement pathway to kill tumor cells. Cancer Res 2005, 65:4614-4622. 10.1158/0008-5472.CAN-04-2253, 15930279.
38. Feng Y, Wan H, Liu J, Zhang R, Ma Q, Han B, Xiang Y, Che J, Cao H, Fei X, Qiu W. The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer. Oncol Rep 2010, 23:941-948.
39. Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 1996, 271:19530-19536. 10.1074/jbc.271.32.19530, 8702646.
40. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806. 10.1126/science.1164368, 2848990, 18772397.
41. Elston CW. The assessment of histological differentiation in breast cancer. Aust N Z J Surg 1984, 54:11-15. 10.1111/j.1445-2197.1984.tb06677.x, 6586161.
42. Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA 2008, 299:1574-1587. 10.1001/jama.299.13.1574, 18387932.
43. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008, 8:83-93. 10.1038/nrc2290, 18094723.
44. Steeg PS, Abrams JS. Cancer prognostics: past, present and p27. Nat Med 1997, 3:152-154. 10.1038/nm0297-152, 9018230.